Future Fields
- Biotech – food & agriculture
- Biotech – industrial & Environmental
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Biotech or pharma, animal health
Leveraging Drosophila melanogaster to produce your difficult-to-express protein at scale. Tackling expression challenges, host-cell toxicity, large volume requirements, and cost efficiency, we help biotech/biopharma conserve budget and make great proteins, unlocking new products and workflows. The EntoEngine’s multicellular and tissue-specific expression services are especially suited for companies that require a bespoke approach to difficult to express proteins or low/no-yield proteins without sacrificing quality, sustainability, or affordability.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}